bevacizumab,sintilimab
eli lilly,innovent biologics,etana
['sintilimab', 'nsclc', 'sclc']
#esmo22 positive trial - addition of sintilimab to chemotherapy improved outcomes in #egfr mutant nsclc - better pfs and rr (os immature). interesting data - chemo-io providing benefit without vegf in egfr? 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him